Constrained Balloon Combined With Drug-coated Balloon Angioplasty for Femoropopliteal Lesion - Trial NCT05894460
Access comprehensive clinical trial information for NCT05894460 through Pure Global AI's free database. This phase not specified trial is sponsored by Xuanwu Hospital, Beijing and is currently Recruiting. The study focuses on Peripheral Arterial Disease. Target enrollment is 254 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Xuanwu Hospital, Beijing
Timeline & Enrollment
N/A
Jun 27, 2023
Dec 31, 2024
Primary Outcome
Primary patency
Summary
This study will assess the safety and efficacy of Chocolate balloons as a combination with
 drug-coated balloons in the treatment of popliteal artery lesions in lower limb
 atherosclerotic occlusive disease and will compare them with conventional balloons.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05894460
Device Trial